| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.649 | 31.601 | 29.212 | 26.116 | 18.675 | 12.887 | 36.330 | 60.216 | 122.384 | 129.031 |
| Total Income - EUR | 28.671 | 31.601 | 29.212 | 26.116 | 18.675 | 15.500 | 36.330 | 60.220 | 133.064 | 129.043 |
| Total Expenses - EUR | 24.170 | 33.529 | 27.950 | 24.074 | 18.119 | 21.768 | 20.729 | 18.154 | 18.637 | 21.294 |
| Gross Profit/Loss - EUR | 4.501 | -1.929 | 1.262 | 2.042 | 556 | -6.268 | 15.601 | 42.066 | 114.426 | 107.749 |
| Net Profit/Loss - EUR | 3.641 | -2.245 | 970 | 1.781 | 370 | -6.389 | 15.245 | 41.475 | 113.122 | 103.955 |
| Employees | 3 | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Sanomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.800 | 3.918 | 3.548 | 3.186 | 2.834 | 2.652 | 1.977 | 1.247 | 667 | 0 |
| Current Assets | 20.087 | 16.337 | 15.893 | 17.742 | 15.990 | 10.512 | 13.442 | 44.841 | 119.195 | 127.699 |
| Inventories | 913 | 1.040 | 1.163 | 834 | 822 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.063 | 2.056 | 2.012 | 2.233 | 1.975 | 424 | 0 | 21.889 | 90.829 | 26.140 |
| Cash | 17.111 | 13.240 | 12.717 | 14.676 | 13.193 | 10.088 | 13.442 | 22.952 | 28.366 | 101.559 |
| Shareholders Funds | 8.992 | 2.757 | 3.680 | 5.393 | 5.659 | -838 | 14.425 | 44.884 | 116.520 | 107.334 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.894 | 17.498 | 15.761 | 15.535 | 13.165 | 14.002 | 1.104 | 1.204 | 3.342 | 20.364 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sanomed Srl